The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of nintedanib and capecitabine in refractory metastatic colorectal cancer.
 
Patrick McKay Boland
Honoraria - Boston Biomedical
Consulting or Advisory Role - Merrimack; Sirtex Medical
Research Funding - Advaxis (Inst); Athenex (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Genentech/Roche (Inst); Ipsen (Inst); Merck (Inst); Merrimack (Inst); Theradiag (Inst)
 
Marwan Fakih
Honoraria - Sirtex Medical
Consulting or Advisory Role - Amgen; Array BioPharma; Genentech/Roche
Speakers' Bureau - Amgen; Taiho Pharmaceutical
Research Funding - Merck (Inst); Novartis (Inst)
 
Dean Lim
No Relationships to Disclose
 
Kristopher Attwood
No Relationships to Disclose
 
Wei Tan
No Relationships to Disclose
 
Michalis Mastri
No Relationships to Disclose
 
Robert Bies
No Relationships to Disclose
 
Christos Fountzilas
No Relationships to Disclose
 
Renuka V. Iyer
Honoraria - Ipsen
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Eisai; Eisai; Ipsen; Lexicon; Merck; Merck; Novartis; Novartis
Research Funding - Cleveland BioLabs (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Wen Wee Ma
Consulting or Advisory Role - Merrimack
Research Funding - Athenex (Inst); Merrimack (Inst)